LIS Technologies Inc.
LIS Technologies Inc.
LIS Technologies Inc. Contracts Leading Construction Specialist to Oversee Retrofitting of its Secured Facility in Oak Ridge, Tennessee
Oak Ridge, Tennessee, Sept. 26, 2024 (GLOBE NEWSWIRE) — LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has engaged a leading construction specialist to oversee the design and redevelopment of its facility in Oak Ridge, Tennessee, creating a modern and secure space for the Company’s next phase of physical test work.
Following completion of the nearly $1 Million redevelopment, the facility will house LIST’s specialized testing equipment aimed at refining and demonstrating the capabilities of its technology. It will include dedicated space for the Phase 1 Test Loop demonstration of the Company’s proprietary, patented laser uranium enrichment technology, serving as the central hub for its development. Additionally, the facility will support the production of stable isotopes for medical and scientific research. The initial design and build-out will ensure the facility is properly equipped to host operations and lay the groundwork for future physical test work.
“The new LIST headquarters in Oak Ridge, TN will be converted into a “closed area,” which will allow LIST to perform research on its laser enrichment technology and protect said technology as Classified in accordance with NRC regulations, prior to DOE declaring the LIST technology as Restricted Data,” said Keith Everly, Head of Security and IP Management of LIS Technologies Inc. “We will work closely with the regulatory frameworks to streamline the process and ensure regulatory compliance of CRISLA, the technology that LIST plans to commercialize.”
Figure 1 – LIS Technologies Inc. Contracts Leading Construction Specialist to Oversee Retrofitting of its Secured Facility in Oak Ridge, Tennessee
“I’m thrilled that major upgrades to our new facility in Oak Ridge will start soon, which will allow us to take the next steps towards the rebirth of our patented, US-origin laser enrichment technology,” said Christo Liebenberg, Chief Executive Officer of LIS Technologies Inc. “We are taking a pro-active approach with the security upgrade. It is a short matter of time before we demonstrate that the CRISLA process can produce practical quantities of enriched uranium product. We want our facility to be ready and secure before the DOE classifies the technology. This is a major threshold for the Company and positions us closer towards to our ultimate goal of enriching uranium for the next generation of advanced nuclear reactors in the United States.”
Story continues
The proprietary technology is the only proven US-origin laser enrichment solution and is scalable, efficient, and cost-effective. Optimized for both Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU), it overcomes the limitations of traditional pulsed 16µm CO2 lasers, featuring a streamlined design due to its lower absorption and shorter wavelength at 5.3µm. Demonstrated in the 1980s and 90s, this technology is protected by a patent from the United States Patent and Trademark Office (USPTO).
About LIS Technologies Inc.
LIS Technologies Inc. (LIST) is a USA based, proprietary developer of a patented advanced laser technology, making use of infrared wavelengths to selectively excite the molecules of desired isotopes to separate them from other isotopes. The Laser Isotope Separation Technology (L.I.S.T) has a huge range of applications, including being the only USA-origin (and patented) laser uranium enrichment company, and several major advantages over traditional methods such as gas diffusion, centrifuges, and prior art laser enrichment. The LIST proprietary laser-based process is more energy-efficient and has the potential to be deployed with highly competitive capital and operational costs. L.I.S.T is optimized for LEU (Low Enriched Uranium) for existing civilian nuclear power plants, High-Assay LEU (HALEU) for the next generation of Small Modular Reactors (SMR) and Microreactors, the production of stable isotopes for medical and scientific research, and applications in quantum computing manufacturing for semiconductor technologies. The Company employs a world class nuclear technical team working alongside leading nuclear entrepreneurs and industry professionals, possessing strong relationships with government and private nuclear industries.
For more information please visit: www.LaserIsTech.com
For further information, please contact:
Email: info@laseristech.com
Telephone: 800-388-5492
Follow us on Twitter
Follow us on LinkedIn
Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “will”, “should”, “could”, “would” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties and other factors, which may be beyond our control. For LIS Technologies Inc., particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following which are, and will be, exacerbated by any worsening of global business and economic environment: (i) risks related to the development of new or advanced technology, including difficulties with design and testing, cost overruns, development of competitive technology, loss of key individuals and uncertainty of success of patent filing, (ii) our ability to obtain contracts and funding to be able to continue operations and (iii) risks related to uncertainty regarding our ability to commercially deploy a competitive laser enrichment technology, (iv) risks related to the impact of government regulation and policies including by the DOE and the U.S. Nuclear Regulatory Commission; and other risks and uncertainties discussed in this and our other filings with the SEC. Only after successful completion of our Phase 2 Pilot Plant demonstration will LIS Technologies be able to make realistic economic predictions for a Commercial Facility. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Attachment
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f563e0d0974569aed9afa3fddb3a11&url=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Flis-technologies-inc-contracts-leading-130000283.html&c=17711969212327210702&mkt=en-us
Author :
Publish date : 2024-09-26 01:59:00
Copyright for syndicated content belongs to the linked Source.